Abiopharma

New Form 4 - Silence Therapeutics plc Filed: 2025-06-20 AccNo: 0001104659-25-060862 Size: 7 KB

Evolent reiterates Q2 and full year guidance for Adjusted EBITDA

New Form 8-K - Evolent Health, Inc. Filed: 2025-06-20 AccNo: 0001628908-25-000098 Size: 311 KB Item 1.01: Entry into a Material Definitive Agreement Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

Madrigal Receives Positive CHMP Opinion for Resmetirom(Rezdiffra™) for the Treatment of MASH with Moderate to Advanced Liver Fibrosis

New Form 8-K - PetVivo Holdings, Inc. Filed: 2025-06-20 AccNo: 0001641172-25-015708 Size: 544 KB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 9.01: Financial Statements and Exhibits

New Form 8-K - PROVECTUS BIOPHARMACEUTICALS, INC. Filed: 2025-06-20 AccNo: 0001641172-25-015695 Size: 208 KB Item 5.07: Submission of Matters to a Vote of Security Holders

New Form SCHEDULE 13D - Tharimmune, Inc. Filed: 2025-06-20 AccNo: 0001641172-25-015693 Size: 12 KB

New Form 6-K - So-Young International Inc. Filed: 2025-06-20 AccNo: 0001104659-25-060825 Size: 19 KB

New Form 10-K - Modular Medical, Inc. Filed: 2025-06-20 AccNo: 0001213900-25-055793 Size: 6 MB

New Form 8-K - Veradigm Inc. Filed: 2025-06-20 AccNo: 0001193125-25-143139 Size: 1 MB Item 1.01: Entry into a Material Definitive Agreement Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant Item 9.01: Financial Statements and Exhibits

New Form 8-K - Tharimmune, Inc. Filed: 2025-06-20 AccNo: 0001641172-25-015675 Size: 874 KB Item 1.01: Entry into a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits

New Form 6-K - AC Immune SA Filed: 2025-06-20 AccNo: 0000950103-25-007642 Size: 11 MB

New Form 8-K - HARROW, INC. Filed: 2025-06-20 AccNo: 0001641172-25-015665 Size: 273 KB Item 5.07: Submission of Matters to a Vote of Security Holders

New Form 8-K - Annovis Bio, Inc. Filed: 2025-06-20 AccNo: 0001104659-25-060784 Size: 205 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

New Form EFFECT - MANGOCEUTICALS, INC. Filed: 2025-06-18 AccNo: 9999999995-25-001956 Size: 1 KB